Head Office
Sun Pharmaceutical Industries Ltd.
Sun House, CTS No. 201 B/1,
Western Express Highway,
Goregaon (E), Mumbai 400063
Customer Service
Phone: 1 800 818 4555
Phone: 1 833 786 4636 (US)
Phone: 1 800 406 7984 (Ranbaxy)
Email: drugsafety@sunpharma.com
_______
About Sun Pharma
Sun Pharma was once operational in the market with just five products and five people, today it has grown to a company commanding the largest market capitalization in the pharmaceuticals sector. Founded in 1983 by Dilip Shanghvi, the company manufactures and sells pharmaceutical formulations and APIs (active pharmaceutical ingredients). Headquartered at Mumbai, the areas of contribution include cardiology, neurology, diabetology, gastroenterology, and psychiatry. The company started in Gujarat with drugs that were formulated to treat psychiatry ailments. In 1987, Sun Pharma introduced medicines to treat cardiology ailments, followed by the gastroenterology product line in 1989. One of the most important events in the history of the company was its acquisition of Ranbaxy in 2014. With the acquisition, Sun Pharma became the largest pharmaceutical company in India, and was also listed as the 5th largest specialty generic company in the world.
Much of Sun Pharma’s sale is recorded outside India (close to 72%), which includes a major chunk from the US market. In fact the US alone accounts for 50% of the total revenue. As of today, Sun Pharma manufactures its formulations in 26 locations. Outside India, some of the major plants can be located at Mexico, Canada, the US, Brazil, and Israel. The success story of the company has been published and lauded internationally. Some of the most important APIs manufactured by the company include warfarin, clorazepate, carbamazepine, as well as steroids, anti-cancer, and controlled substances. Some of the popular brands in the portfolio include Oncotron, Cifran, Histac, Distenil, Keflor, Reflin, Roscillin, Sporidex, Fortwin, Ketanov, Calmpose, Prolinate, Syndopa, Cereloid, Mesacol Enema, Sizopin, Duracard, and Phosphorid, to name a few.
Sun Pharma is a company that chose to focus on patients and doctors, exactly the way a consumer goods company does. The better approach towards pricing strategy and distribution network clearly reflects on the numbers. The company has earned an operating profit of INR 45 for every INR 100 of the revenue. This is impressive as compared to some of the major competitors. The profitability has allowed the company to crank up its growth engine and that is evident with the increased number of strategic acquisitions, in India as well as the United States. Sun Pharma has successfully made 17 acquisitions. You can visit the website to learn more on the company, the formulations or the APIs. You can select the country from the drop down to discover products marketed and sold in your region. If you want to register a complaint or share feedback, you can do so by dialing the customer assistance number, or by filling up the contact form available on the website.
